![James Dentzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Dentzer
Directeur Général chez
CURIS, INC.
Fortune : 116 949 $ au 31/05/2026
Profil
James E.
Dentzer is President, Chief Executive Officer & Director at Curis, Inc. since 2019 and Independent Director at Imunon, Inc. since 2022.
Former roles include Chief Financial Officer-DuPont Flooring Systems at EIDP, Inc., Controller at Biogen, Inc. from 2003 to 2006, Chief Financial Officer at Amicus Therapeutics, Inc. from 2006 to 2009, Chief Financial Officer at Valeritas, Inc. from 2010 to 2013, and Chief Financial Officer at Dicerna Pharmaceuticals, Inc. from 2013 to 2015.
Education includes undergraduate studies at Boston College and an MBA from The University of Chicago Booth School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CURIS, INC. 0,38 % | 23/03/2026 | 148 730 ( 0,38 % ) | 84 330 $ | 31/05/2026 |
IMUNON, INC. 0,59 % | 22/05/2026 | 14 963 ( 0,59 % ) | 32 619 $ | 31/05/2026 |
Postes actifs de James Dentzer
| Sociétés | Poste | Début |
|---|---|---|
| CURIS, INC. | Directeur Général | 24/09/2018 |
| IMUNON, INC. | Directeur/Membre du Conseil | 03/09/2022 |
Anciens postes connus de James Dentzer
| Sociétés | Poste | Fin |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 15/12/2015 |
| VALERITAS INC | Directeur Financier/CFO | 01/12/2013 |
| AMICUS THERAPEUTICS, INC. | Directeur Financier/CFO | 29/10/2009 |
| BIOGEN INC. | Comptroller/Controller/Auditor | - |
| E I DU PONT DE NEMOURS AND CO | Corporate Officer/Principal | - |
Formation de James Dentzer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries Manufactures and sells seed & crop protection products | Process Industries |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
